About us
Who we are
Our strategy
How we are funded
Our people
Governance and structure
Reports and statements
Suppliers
Our strategy
Our strategy
Global health
Neurodegeneration
Rare Disease
Respiratory health
Working with us
Support for MRC researchers
Helping charities
Our partners
Available technologies
Advise & Connect: Covid-19
Funding
LifeArc Ventures
Rare disease translational challenges
Development Gap Fund
Current funding opportunities
Capabilities
Drug discovery
Antibody humanisation
IP management and technology transfer
Diagnostics development
Careers
Working at LifeArc
Our culture
Benefits and rewards
Students and fellows
How to apply
Job vacancies
News
Latest news
Case studies
Reports and publications
Newsletter
Rare disease translational challenges
We help scientists progress their promising research into rare disease
Home
Our strategy
Rare Disease
Rare disease translational challenges
Grants, funding and support for academics
Translational Rare Disease Centres
£40 million to build on the UK’s rich, rare disease research base. (Closed to new applications)
Joint funding call: Funding for Epidermolysis Bullosa
LifeArc and DEBRA Austria in joint call for projects to develop therapeutics for any type of Epidermolysis Bullosa - apply by 10 September 2023
Philanthropic Fund
Grants and funding for researchers working to advance new treatments and diagnostics for rare diseases
Muscular Dystrophy Translational Research Fund
A one-off, joint £1m fund in association with Muscular Dystrophy UK (MDUK)
LifeArc Gene Therapy Innovation Fund
£5m annual fund for gene therapy technologies, which includes support from the world-class network of Innovation Hubs for Gene Therapies
LifeArc & GOSH Charity Fund
Joint funding scheme for GOSH researchers to drive their discoveries towards new tests and treatments for childhood rare diseases
LifeArc & Action Medical Research Joint Fund
Annual joint funding round of up to £1 million (closed 14 June 2023)
Scottish CSO Fund
A joint funding call made in 2020, which provided £300,000 to fund Scottish translational research into rare diseases